JP2024506713A5 - - Google Patents

Info

Publication number
JP2024506713A5
JP2024506713A5 JP2023549595A JP2023549595A JP2024506713A5 JP 2024506713 A5 JP2024506713 A5 JP 2024506713A5 JP 2023549595 A JP2023549595 A JP 2023549595A JP 2023549595 A JP2023549595 A JP 2023549595A JP 2024506713 A5 JP2024506713 A5 JP 2024506713A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
polysaccharide
amino acid
gas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023549595A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024506713A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/016630 external-priority patent/WO2022178015A1/en
Publication of JP2024506713A publication Critical patent/JP2024506713A/ja
Publication of JP2024506713A5 publication Critical patent/JP2024506713A5/ja
Pending legal-status Critical Current

Links

JP2023549595A 2021-02-17 2022-02-16 多糖およびそのポリペプチドコンジュゲートの精製方法 Pending JP2024506713A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163150516P 2021-02-17 2021-02-17
US63/150,516 2021-02-17
US202163288387P 2021-12-10 2021-12-10
US63/288,387 2021-12-10
PCT/US2022/016630 WO2022178015A1 (en) 2021-02-17 2022-02-16 Purification processes for polysaccharides and polypeptide conjugates thereof

Publications (2)

Publication Number Publication Date
JP2024506713A JP2024506713A (ja) 2024-02-14
JP2024506713A5 true JP2024506713A5 (cg-RX-API-DMAC7.html) 2025-02-27

Family

ID=82931694

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023549595A Pending JP2024506713A (ja) 2021-02-17 2022-02-16 多糖およびそのポリペプチドコンジュゲートの精製方法

Country Status (9)

Country Link
US (1) US20240000926A1 (cg-RX-API-DMAC7.html)
EP (1) EP4294452A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024506713A (cg-RX-API-DMAC7.html)
KR (1) KR20230146620A (cg-RX-API-DMAC7.html)
AU (1) AU2022221621A1 (cg-RX-API-DMAC7.html)
CA (1) CA3208716A1 (cg-RX-API-DMAC7.html)
IL (1) IL305201A (cg-RX-API-DMAC7.html)
TW (1) TW202302152A (cg-RX-API-DMAC7.html)
WO (1) WO2022178015A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023538365A (ja) 2020-08-19 2023-09-07 バックスサイト・インコーポレイテッド 担体－タンパク質多糖結合方法
MX2024002779A (es) 2021-09-09 2024-06-11 Affinivax Inc Vacunas neumocócicas multivalentes.
CN115894604B (zh) * 2022-12-16 2024-01-23 康日百奥生物科技(苏州)有限公司 重组蛋白澄清纯化方法
WO2025193903A1 (en) 2024-03-15 2025-09-18 Affinivax, Inc. Pneumococcal polysaccharide compositions and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7709009B2 (en) * 2003-07-31 2010-05-04 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for streptococcus pyogenes
US8287885B2 (en) * 2007-09-12 2012-10-16 Novartis Ag GAS57 mutant antigens and GAS57 antibodies
PT2349520T (pt) * 2008-10-27 2016-08-16 Glaxosmithkline Biologicals Sa Método de purificação para hidrato de carbono de estreptococos grupo a
EP2311947A1 (en) * 2009-10-14 2011-04-20 Ludwig-Maximilians-Universität München Protein synthesis via click chemistry
WO2013020090A2 (en) * 2011-08-04 2013-02-07 The Regents Of The University Of California STREPTOCOCCAL GLcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM
CA2903716C (en) * 2013-03-08 2019-04-09 Pfizer Inc. Immunogenic fusion polypeptides
US11951165B2 (en) * 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
IL267709B2 (en) * 2016-12-30 2025-04-01 Vaxcyte Inc Polypeptide-antigen conjugates with unnatural amino acids
CN107737334B (zh) * 2017-09-05 2020-01-17 中国科学院微生物研究所 一种预防a型链球菌感染的广谱多联亚单位疫苗
BR112020015696A2 (pt) * 2018-02-05 2020-12-08 Sanofi Pasteur, Inc. Composição de conjugado polissacarídeo-proteína pneumocócico multivalente
WO2019152921A1 (en) * 2018-02-05 2019-08-08 Sanofi Pasteur Inc. Multivalent pneumococcal polysaccharide-protein conjugate composition
TW202011985A (zh) * 2018-04-18 2020-04-01 韓商Ｓｋ生物科學股份有限公司 肺炎鏈球菌的莢膜多醣類以及其免疫原性接合體
CN109045292A (zh) * 2018-11-08 2018-12-21 山东大学 一种a群链球菌寡糖蛋白缀合物及其制备方法与应用
SG11202110803YA (en) * 2019-04-02 2021-10-28 Vaxcyte Inc Optimized cell-free synthesis of invasion plasmid antigen b and related compositions and methods of use
CN115175697A (zh) * 2020-02-18 2022-10-11 Vaxcyte公司 具有多糖-蛋白质缀合物的a组链球菌免疫原性组合物

Similar Documents

Publication Publication Date Title
US12241098B2 (en) Process and system for obtaining botulinum neurotoxin
KR101545641B1 (ko) 헤모필루스 인플루엔자에 비 형을 위한 배양 배지
US20100272755A1 (en) Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
AU2019404924B2 (en) O-linked glycosylation recognition motifs
CN114667343A (zh) 大肠杆菌组合物及其方法
CA3185642A1 (en) Modified exotoxin a proteins
JP2008528052A (ja) 連鎖球菌の莢膜多糖類の精製
CN106794237A (zh) 经修饰的宿主细胞及其用途
CN115803087A (zh) 多价疫苗组合物及其用途
WO2019016188A1 (en) IMMUNOGENIC COMPOSITION
EP3140414B1 (en) Purification of secreted polysaccharides from s. agalactiae
KR20210146392A (ko) 침습 플라스미드 항원 b의 최적화된 무세포 합성 및 관련 조성물 및 사용 방법
JP2024517754A (ja) Ｏ－結合型グリコシル化に十分な最小シークオン
RU2407792C1 (ru) СПОСОБ ПОЛУЧЕНИЯ IgAl-ПРОТЕАЗЫ ИЗ КУЛЬТУРЫ NEISSERIA MENINGITIDIS СЕРОГРУППЫ А И ИММУНОГЕННЫЙ ПРЕПАРАТ НА ЕЕ ОСНОВЕ
WO2025196270A1 (en) Outer membrane vesicle vaccines for the prevention of n. gonorrhoeae and methods of making and using thereof
JP2026509192A (ja) 第２のポリペプチドパートナーとのイソペプチド結合を有する複合糖質ポリペプチドを生成するための組成物および方法ならびにその使用
CN121646639A (zh) 经修饰的蛋白质
EP2942396A1 (en) Polysaccharides produced by CPSC mutants